research use only

Catadegbrutinib (BGB-16673) BTK degrader

Cat.No.E1993

Catadegbrutinib (BGB-16673) is an inhibitor of Bruton’s tyrosine kinase (Btk) and can be used in research for the treatment of autoimmune and inflammatory diseases.
Jump to

Quality Control

Batch: Purity: 99.48%
99.48
Selleck AI:Q&A of Catadegbrutinib (BGB-16673): Insights Rooted in Extensive Publications, Every Answer Cited
AI will take about 1 minute to answer this question... 0%

Solubility in DMSO or Water

In vitro
Batch:

DMSO : 100 mg/mL (117.5 mM)
(Moisture-contaminated DMSO may reduce solubility. Use fresh, anhydrous DMSO.)

Water : Insoluble

Ethanol : Insoluble

The solubility data above are all experimental results (not literature values).

Molarity Calculator

Mass Concentration Volume Molecular Weight
Dilution Calculator Molecular Weight Calculator

In vivo
Batch:

In vivo Formulation Calculator (Clear solution)

Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)

mg/kg
g
μL

Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)

% DMSO
%
% Tween 80
% ddH2O
% DMSO
+
%

Calculation results:

Working concentration: mg/ml;

Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )

Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.

Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.

Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.

Read more about Catadegbrutinib (BGB-16673) solubility in DMSO or water

Working Concentrations for Cell Culture Treatment

Search directly for a cell line, or select a cell line to find matched working concentrations

Read more about Catadegbrutinib (BGB-16673) working concentrations for cell culture treatment

×

Selectivity & Specificity

Catadegbrutinib (BGB-16673) is a potent inhibitor of BTK (0.69 ± 0.091 nM), CRBN-DBB1 complex (316 ± 82 nM). Catadegbrutinib (BGB-16673) exhibits the greatest inhibitory potency toward BTK (IC50 = 0.69 ± 0.091 nM).

Read more about selectivity & specificity

Mechanism of Action

Information Catadegbrutinib (BGB-16673) is a potent, highly selective BTK targeted protein degrader. It affects B-cell receptor (BCR) signaling by inducing the ubiquitination and proteasomal degradation of wild-type and mutant BTK, effectively inhibiting B-cell proliferation and tumor growth in B-cell malignancies.

Read more about Catadegbrutinib (BGB-16673) IC50 for cell-based and cell-free assays

Primary Applications and Mechanism of Action

Read more about Catadegbrutinib (BGB-16673) Mechanism of Action

Chemical Information, Storage & Stability

Molecular Weight 851.01 Formula

C47H54N12O4

Storage (From the date of receipt)
CAS No. 2736508-60-2 Download SDF Storage of Stock Solutions

Read more about storage & stability

Please select the combination compounds (Multiple selections allowed)
Please select a combination compound first

Read more comparative analysis about Catadegbrutinib (BGB-16673)

Tech Support

Handling Instructions

Tel: +1-832-582-8158 Ext:3

If you have any other enquiries, please leave a message.